nodes	percent_of_prediction	percent_of_DWPC	metapath
Morphine—ABCB1—ovarian cancer	0.293	1	CbGaD
Morphine—UGT2B7—Epirubicin—ovarian cancer	0.136	0.322	CbGbCtD
Morphine—ABCB1—Topotecan—ovarian cancer	0.0465	0.11	CbGbCtD
Morphine—CYP2C8—Paclitaxel—ovarian cancer	0.034	0.0804	CbGbCtD
Morphine—ABCB1—Vinorelbine—ovarian cancer	0.0328	0.0775	CbGbCtD
Morphine—CYP2D6—Vinorelbine—ovarian cancer	0.0309	0.073	CbGbCtD
Morphine—CYP3A4—Topotecan—ovarian cancer	0.0279	0.0659	CbGbCtD
Morphine—ABCB1—Paclitaxel—ovarian cancer	0.023	0.0544	CbGbCtD
Morphine—CYP3A4—Vinorelbine—ovarian cancer	0.0196	0.0464	CbGbCtD
Morphine—ABCB1—Docetaxel—ovarian cancer	0.0166	0.0394	CbGbCtD
Morphine—CYP3A4—Paclitaxel—ovarian cancer	0.0138	0.0326	CbGbCtD
Morphine—ABCB1—Doxorubicin—ovarian cancer	0.0124	0.0293	CbGbCtD
Morphine—CYP2D6—Doxorubicin—ovarian cancer	0.0117	0.0276	CbGbCtD
Morphine—CYP3A4—Docetaxel—ovarian cancer	0.00997	0.0236	CbGbCtD
Morphine—CYP3A4—Doxorubicin—ovarian cancer	0.00743	0.0176	CbGbCtD
Morphine—Naloxone—TLR4—ovarian cancer	0.00297	0.64	CrCbGaD
Morphine—Naloxone—ESR1—ovarian cancer	0.000832	0.179	CrCbGaD
Morphine—Naltrexone—ABCB1—ovarian cancer	0.000484	0.105	CrCbGaD
Morphine—Naloxone—ABCB1—ovarian cancer	0.000353	0.0762	CrCbGaD
Morphine—Loss of consciousness—Docetaxel—ovarian cancer	0.000162	0.000656	CcSEcCtD
Morphine—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000161	0.000655	CcSEcCtD
Morphine—Weight decreased—Epirubicin—ovarian cancer	0.000161	0.000653	CcSEcCtD
Morphine—Hyperglycaemia—Epirubicin—ovarian cancer	0.000161	0.000652	CcSEcCtD
Morphine—Cough—Docetaxel—ovarian cancer	0.000161	0.000651	CcSEcCtD
Morphine—Insomnia—Paclitaxel—ovarian cancer	0.00016	0.00065	CcSEcCtD
Morphine—Convulsion—Docetaxel—ovarian cancer	0.000159	0.000646	CcSEcCtD
Morphine—Paraesthesia—Paclitaxel—ovarian cancer	0.000159	0.000645	CcSEcCtD
Morphine—Hypertension—Docetaxel—ovarian cancer	0.000159	0.000644	CcSEcCtD
Morphine—Drowsiness—Epirubicin—ovarian cancer	0.000159	0.000644	CcSEcCtD
Morphine—Dyspnoea—Paclitaxel—ovarian cancer	0.000158	0.00064	CcSEcCtD
Morphine—Somnolence—Paclitaxel—ovarian cancer	0.000157	0.000639	CcSEcCtD
Morphine—Arthralgia—Docetaxel—ovarian cancer	0.000157	0.000635	CcSEcCtD
Morphine—Chest pain—Docetaxel—ovarian cancer	0.000157	0.000635	CcSEcCtD
Morphine—Nausea—Vinorelbine—ovarian cancer	0.000156	0.000634	CcSEcCtD
Morphine—Renal failure—Epirubicin—ovarian cancer	0.000156	0.000633	CcSEcCtD
Morphine—Dyspepsia—Paclitaxel—ovarian cancer	0.000156	0.000632	CcSEcCtD
Morphine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000156	0.000631	CcSEcCtD
Morphine—Stomatitis—Epirubicin—ovarian cancer	0.000155	0.000628	CcSEcCtD
Morphine—Conjunctivitis—Epirubicin—ovarian cancer	0.000154	0.000626	CcSEcCtD
Morphine—Urinary tract infection—Epirubicin—ovarian cancer	0.000154	0.000626	CcSEcCtD
Morphine—Dysuria—Doxorubicin—ovarian cancer	0.000154	0.000625	CcSEcCtD
Morphine—Decreased appetite—Paclitaxel—ovarian cancer	0.000154	0.000625	CcSEcCtD
Morphine—Dry mouth—Docetaxel—ovarian cancer	0.000153	0.000621	CcSEcCtD
Morphine—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000153	0.00062	CcSEcCtD
Morphine—Fatigue—Paclitaxel—ovarian cancer	0.000153	0.000619	CcSEcCtD
Morphine—Sweating—Epirubicin—ovarian cancer	0.000152	0.000617	CcSEcCtD
Morphine—Constipation—Paclitaxel—ovarian cancer	0.000151	0.000614	CcSEcCtD
Morphine—Pain—Paclitaxel—ovarian cancer	0.000151	0.000614	CcSEcCtD
Morphine—Confusional state—Docetaxel—ovarian cancer	0.000151	0.000614	CcSEcCtD
Morphine—Hepatobiliary disease—Epirubicin—ovarian cancer	0.00015	0.000609	CcSEcCtD
Morphine—Anaphylactic shock—Docetaxel—ovarian cancer	0.00015	0.000609	CcSEcCtD
Morphine—Oedema—Docetaxel—ovarian cancer	0.00015	0.000609	CcSEcCtD
Morphine—Infection—Docetaxel—ovarian cancer	0.000149	0.000605	CcSEcCtD
Morphine—Weight decreased—Doxorubicin—ovarian cancer	0.000149	0.000605	CcSEcCtD
Morphine—Hyperglycaemia—Doxorubicin—ovarian cancer	0.000149	0.000603	CcSEcCtD
Morphine—Shock—Docetaxel—ovarian cancer	0.000148	0.000599	CcSEcCtD
Morphine—Nervous system disorder—Docetaxel—ovarian cancer	0.000147	0.000597	CcSEcCtD
Morphine—Thrombocytopenia—Docetaxel—ovarian cancer	0.000147	0.000596	CcSEcCtD
Morphine—Drowsiness—Doxorubicin—ovarian cancer	0.000147	0.000596	CcSEcCtD
Morphine—Tachycardia—Docetaxel—ovarian cancer	0.000147	0.000594	CcSEcCtD
Morphine—Feeling abnormal—Paclitaxel—ovarian cancer	0.000146	0.000592	CcSEcCtD
Morphine—Skin disorder—Docetaxel—ovarian cancer	0.000146	0.000591	CcSEcCtD
Morphine—Bradycardia—Epirubicin—ovarian cancer	0.000145	0.000589	CcSEcCtD
Morphine—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000145	0.000587	CcSEcCtD
Morphine—Renal failure—Doxorubicin—ovarian cancer	0.000144	0.000586	CcSEcCtD
Morphine—Stomatitis—Doxorubicin—ovarian cancer	0.000143	0.000581	CcSEcCtD
Morphine—Anorexia—Docetaxel—ovarian cancer	0.000143	0.00058	CcSEcCtD
Morphine—Rhinitis—Epirubicin—ovarian cancer	0.000143	0.00058	CcSEcCtD
Morphine—Urinary tract infection—Doxorubicin—ovarian cancer	0.000143	0.000579	CcSEcCtD
Morphine—Conjunctivitis—Doxorubicin—ovarian cancer	0.000143	0.000579	CcSEcCtD
Morphine—Hepatitis—Epirubicin—ovarian cancer	0.000143	0.000578	CcSEcCtD
Morphine—Hypoaesthesia—Epirubicin—ovarian cancer	0.000142	0.000575	CcSEcCtD
Morphine—Sweating—Doxorubicin—ovarian cancer	0.000141	0.000571	CcSEcCtD
Morphine—Urinary tract disorder—Epirubicin—ovarian cancer	0.000141	0.000571	CcSEcCtD
Morphine—Urticaria—Paclitaxel—ovarian cancer	0.000141	0.000571	CcSEcCtD
Morphine—Oedema peripheral—Epirubicin—ovarian cancer	0.00014	0.00057	CcSEcCtD
Morphine—Hypotension—Docetaxel—ovarian cancer	0.00014	0.000569	CcSEcCtD
Morphine—Connective tissue disorder—Epirubicin—ovarian cancer	0.00014	0.000568	CcSEcCtD
Morphine—Abdominal pain—Paclitaxel—ovarian cancer	0.00014	0.000568	CcSEcCtD
Morphine—Body temperature increased—Paclitaxel—ovarian cancer	0.00014	0.000568	CcSEcCtD
Morphine—Urethral disorder—Epirubicin—ovarian cancer	0.00014	0.000567	CcSEcCtD
Morphine—Hepatobiliary disease—Doxorubicin—ovarian cancer	0.000139	0.000564	CcSEcCtD
Morphine—Visual impairment—Epirubicin—ovarian cancer	0.000137	0.000557	CcSEcCtD
Morphine—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000137	0.000555	CcSEcCtD
Morphine—Insomnia—Docetaxel—ovarian cancer	0.000136	0.000551	CcSEcCtD
Morphine—Paraesthesia—Docetaxel—ovarian cancer	0.000135	0.000547	CcSEcCtD
Morphine—Bradycardia—Doxorubicin—ovarian cancer	0.000134	0.000545	CcSEcCtD
Morphine—Dyspnoea—Docetaxel—ovarian cancer	0.000134	0.000543	CcSEcCtD
Morphine—Somnolence—Docetaxel—ovarian cancer	0.000133	0.000541	CcSEcCtD
Morphine—Eye disorder—Epirubicin—ovarian cancer	0.000133	0.00054	CcSEcCtD
Morphine—Flushing—Epirubicin—ovarian cancer	0.000132	0.000537	CcSEcCtD
Morphine—Rhinitis—Doxorubicin—ovarian cancer	0.000132	0.000536	CcSEcCtD
Morphine—Dyspepsia—Docetaxel—ovarian cancer	0.000132	0.000536	CcSEcCtD
Morphine—Hepatitis—Doxorubicin—ovarian cancer	0.000132	0.000535	CcSEcCtD
Morphine—Hypoaesthesia—Doxorubicin—ovarian cancer	0.000131	0.000532	CcSEcCtD
Morphine—Decreased appetite—Docetaxel—ovarian cancer	0.000131	0.000529	CcSEcCtD
Morphine—Hypersensitivity—Paclitaxel—ovarian cancer	0.000131	0.000529	CcSEcCtD
Morphine—Urinary tract disorder—Doxorubicin—ovarian cancer	0.00013	0.000528	CcSEcCtD
Morphine—Oedema peripheral—Doxorubicin—ovarian cancer	0.00013	0.000527	CcSEcCtD
Morphine—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.00013	0.000526	CcSEcCtD
Morphine—Connective tissue disorder—Doxorubicin—ovarian cancer	0.00013	0.000526	CcSEcCtD
Morphine—Fatigue—Docetaxel—ovarian cancer	0.000129	0.000525	CcSEcCtD
Morphine—Angiopathy—Epirubicin—ovarian cancer	0.000129	0.000525	CcSEcCtD
Morphine—Urethral disorder—Doxorubicin—ovarian cancer	0.000129	0.000524	CcSEcCtD
Morphine—Mediastinal disorder—Epirubicin—ovarian cancer	0.000128	0.000521	CcSEcCtD
Morphine—Constipation—Docetaxel—ovarian cancer	0.000128	0.000521	CcSEcCtD
Morphine—Pain—Docetaxel—ovarian cancer	0.000128	0.000521	CcSEcCtD
Morphine—Chills—Epirubicin—ovarian cancer	0.000128	0.000519	CcSEcCtD
Morphine—Visual impairment—Doxorubicin—ovarian cancer	0.000127	0.000515	CcSEcCtD
Morphine—Asthenia—Paclitaxel—ovarian cancer	0.000127	0.000515	CcSEcCtD
Morphine—Pruritus—Paclitaxel—ovarian cancer	0.000125	0.000508	CcSEcCtD
Morphine—Mental disorder—Epirubicin—ovarian cancer	0.000125	0.000506	CcSEcCtD
Morphine—Erythema—Epirubicin—ovarian cancer	0.000124	0.000503	CcSEcCtD
Morphine—Malnutrition—Epirubicin—ovarian cancer	0.000124	0.000503	CcSEcCtD
Morphine—Feeling abnormal—Docetaxel—ovarian cancer	0.000124	0.000502	CcSEcCtD
Morphine—Eye disorder—Doxorubicin—ovarian cancer	0.000123	0.0005	CcSEcCtD
Morphine—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000123	0.000498	CcSEcCtD
Morphine—Flushing—Doxorubicin—ovarian cancer	0.000122	0.000496	CcSEcCtD
Morphine—Flatulence—Epirubicin—ovarian cancer	0.000122	0.000496	CcSEcCtD
Morphine—Tension—Epirubicin—ovarian cancer	0.000122	0.000494	CcSEcCtD
Morphine—Dysgeusia—Epirubicin—ovarian cancer	0.000122	0.000493	CcSEcCtD
Morphine—Diarrhoea—Paclitaxel—ovarian cancer	0.000121	0.000492	CcSEcCtD
Morphine—Nervousness—Epirubicin—ovarian cancer	0.000121	0.000489	CcSEcCtD
Morphine—Back pain—Epirubicin—ovarian cancer	0.00012	0.000487	CcSEcCtD
Morphine—Angiopathy—Doxorubicin—ovarian cancer	0.00012	0.000485	CcSEcCtD
Morphine—Muscle spasms—Epirubicin—ovarian cancer	0.000119	0.000484	CcSEcCtD
Morphine—Mediastinal disorder—Doxorubicin—ovarian cancer	0.000119	0.000482	CcSEcCtD
Morphine—Abdominal pain—Docetaxel—ovarian cancer	0.000119	0.000481	CcSEcCtD
Morphine—Body temperature increased—Docetaxel—ovarian cancer	0.000119	0.000481	CcSEcCtD
Morphine—Chills—Doxorubicin—ovarian cancer	0.000118	0.00048	CcSEcCtD
Morphine—Dizziness—Paclitaxel—ovarian cancer	0.000117	0.000475	CcSEcCtD
Morphine—Vision blurred—Epirubicin—ovarian cancer	0.000117	0.000474	CcSEcCtD
Morphine—Mental disorder—Doxorubicin—ovarian cancer	0.000116	0.000469	CcSEcCtD
Morphine—Ill-defined disorder—Epirubicin—ovarian cancer	0.000115	0.000467	CcSEcCtD
Morphine—Malnutrition—Doxorubicin—ovarian cancer	0.000115	0.000466	CcSEcCtD
Morphine—Erythema—Doxorubicin—ovarian cancer	0.000115	0.000466	CcSEcCtD
Morphine—Anaemia—Epirubicin—ovarian cancer	0.000115	0.000465	CcSEcCtD
Morphine—Agitation—Epirubicin—ovarian cancer	0.000114	0.000462	CcSEcCtD
Morphine—Flatulence—Doxorubicin—ovarian cancer	0.000113	0.000459	CcSEcCtD
Morphine—Tension—Doxorubicin—ovarian cancer	0.000113	0.000457	CcSEcCtD
Morphine—Vomiting—Paclitaxel—ovarian cancer	0.000113	0.000457	CcSEcCtD
Morphine—Dysgeusia—Doxorubicin—ovarian cancer	0.000112	0.000456	CcSEcCtD
Morphine—Malaise—Epirubicin—ovarian cancer	0.000112	0.000454	CcSEcCtD
Morphine—Rash—Paclitaxel—ovarian cancer	0.000112	0.000453	CcSEcCtD
Morphine—Dermatitis—Paclitaxel—ovarian cancer	0.000112	0.000453	CcSEcCtD
Morphine—Nervousness—Doxorubicin—ovarian cancer	0.000112	0.000452	CcSEcCtD
Morphine—Vertigo—Epirubicin—ovarian cancer	0.000111	0.000452	CcSEcCtD
Morphine—Syncope—Epirubicin—ovarian cancer	0.000111	0.000451	CcSEcCtD
Morphine—Leukopenia—Epirubicin—ovarian cancer	0.000111	0.00045	CcSEcCtD
Morphine—Back pain—Doxorubicin—ovarian cancer	0.000111	0.00045	CcSEcCtD
Morphine—Headache—Paclitaxel—ovarian cancer	0.000111	0.00045	CcSEcCtD
Morphine—Hypersensitivity—Docetaxel—ovarian cancer	0.000111	0.000449	CcSEcCtD
Morphine—Muscle spasms—Doxorubicin—ovarian cancer	0.00011	0.000448	CcSEcCtD
Morphine—Palpitations—Epirubicin—ovarian cancer	0.00011	0.000445	CcSEcCtD
Morphine—Loss of consciousness—Epirubicin—ovarian cancer	0.000109	0.000442	CcSEcCtD
Morphine—Cough—Epirubicin—ovarian cancer	0.000108	0.000439	CcSEcCtD
Morphine—Vision blurred—Doxorubicin—ovarian cancer	0.000108	0.000439	CcSEcCtD
Morphine—Asthenia—Docetaxel—ovarian cancer	0.000108	0.000437	CcSEcCtD
Morphine—Convulsion—Epirubicin—ovarian cancer	0.000108	0.000436	CcSEcCtD
Morphine—Hypertension—Epirubicin—ovarian cancer	0.000107	0.000434	CcSEcCtD
Morphine—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000107	0.000432	CcSEcCtD
Morphine—Pruritus—Docetaxel—ovarian cancer	0.000106	0.000431	CcSEcCtD
Morphine—Anaemia—Doxorubicin—ovarian cancer	0.000106	0.00043	CcSEcCtD
Morphine—Arthralgia—Epirubicin—ovarian cancer	0.000106	0.000428	CcSEcCtD
Morphine—Chest pain—Epirubicin—ovarian cancer	0.000106	0.000428	CcSEcCtD
Morphine—Agitation—Doxorubicin—ovarian cancer	0.000106	0.000428	CcSEcCtD
Morphine—Anxiety—Epirubicin—ovarian cancer	0.000105	0.000427	CcSEcCtD
Morphine—Nausea—Paclitaxel—ovarian cancer	0.000105	0.000427	CcSEcCtD
Morphine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000105	0.000425	CcSEcCtD
Morphine—Discomfort—Epirubicin—ovarian cancer	0.000104	0.000423	CcSEcCtD
Morphine—Malaise—Doxorubicin—ovarian cancer	0.000104	0.00042	CcSEcCtD
Morphine—Dry mouth—Epirubicin—ovarian cancer	0.000103	0.000419	CcSEcCtD
Morphine—Vertigo—Doxorubicin—ovarian cancer	0.000103	0.000418	CcSEcCtD
Morphine—Syncope—Doxorubicin—ovarian cancer	0.000103	0.000418	CcSEcCtD
Morphine—Leukopenia—Doxorubicin—ovarian cancer	0.000103	0.000417	CcSEcCtD
Morphine—Diarrhoea—Docetaxel—ovarian cancer	0.000103	0.000417	CcSEcCtD
Morphine—Confusional state—Epirubicin—ovarian cancer	0.000102	0.000414	CcSEcCtD
Morphine—Palpitations—Doxorubicin—ovarian cancer	0.000101	0.000411	CcSEcCtD
Morphine—Anaphylactic shock—Epirubicin—ovarian cancer	0.000101	0.000411	CcSEcCtD
Morphine—Oedema—Epirubicin—ovarian cancer	0.000101	0.000411	CcSEcCtD
Morphine—Loss of consciousness—Doxorubicin—ovarian cancer	0.000101	0.000409	CcSEcCtD
Morphine—Infection—Epirubicin—ovarian cancer	0.000101	0.000408	CcSEcCtD
Morphine—Cough—Doxorubicin—ovarian cancer	0.0001	0.000406	CcSEcCtD
Morphine—Shock—Epirubicin—ovarian cancer	9.96e-05	0.000404	CcSEcCtD
Morphine—Convulsion—Doxorubicin—ovarian cancer	9.95e-05	0.000403	CcSEcCtD
Morphine—Nervous system disorder—Epirubicin—ovarian cancer	9.93e-05	0.000403	CcSEcCtD
Morphine—Dizziness—Docetaxel—ovarian cancer	9.93e-05	0.000403	CcSEcCtD
Morphine—Thrombocytopenia—Epirubicin—ovarian cancer	9.92e-05	0.000402	CcSEcCtD
Morphine—Hypertension—Doxorubicin—ovarian cancer	9.91e-05	0.000402	CcSEcCtD
Morphine—Tachycardia—Epirubicin—ovarian cancer	9.89e-05	0.000401	CcSEcCtD
Morphine—Skin disorder—Epirubicin—ovarian cancer	9.84e-05	0.000399	CcSEcCtD
Morphine—Hyperhidrosis—Epirubicin—ovarian cancer	9.79e-05	0.000397	CcSEcCtD
Morphine—Chest pain—Doxorubicin—ovarian cancer	9.78e-05	0.000396	CcSEcCtD
Morphine—Arthralgia—Doxorubicin—ovarian cancer	9.78e-05	0.000396	CcSEcCtD
Morphine—Anxiety—Doxorubicin—ovarian cancer	9.74e-05	0.000395	CcSEcCtD
Morphine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	9.71e-05	0.000394	CcSEcCtD
Morphine—Discomfort—Doxorubicin—ovarian cancer	9.66e-05	0.000392	CcSEcCtD
Morphine—Anorexia—Epirubicin—ovarian cancer	9.65e-05	0.000392	CcSEcCtD
Morphine—Dry mouth—Doxorubicin—ovarian cancer	9.56e-05	0.000388	CcSEcCtD
Morphine—Vomiting—Docetaxel—ovarian cancer	9.55e-05	0.000387	CcSEcCtD
Morphine—Rash—Docetaxel—ovarian cancer	9.47e-05	0.000384	CcSEcCtD
Morphine—Hypotension—Epirubicin—ovarian cancer	9.46e-05	0.000384	CcSEcCtD
Morphine—Dermatitis—Docetaxel—ovarian cancer	9.46e-05	0.000384	CcSEcCtD
Morphine—Confusional state—Doxorubicin—ovarian cancer	9.45e-05	0.000383	CcSEcCtD
Morphine—Headache—Docetaxel—ovarian cancer	9.41e-05	0.000381	CcSEcCtD
Morphine—Anaphylactic shock—Doxorubicin—ovarian cancer	9.37e-05	0.00038	CcSEcCtD
Morphine—Oedema—Doxorubicin—ovarian cancer	9.37e-05	0.00038	CcSEcCtD
Morphine—Infection—Doxorubicin—ovarian cancer	9.31e-05	0.000378	CcSEcCtD
Morphine—Musculoskeletal discomfort—Epirubicin—ovarian cancer	9.23e-05	0.000374	CcSEcCtD
Morphine—Shock—Doxorubicin—ovarian cancer	9.22e-05	0.000374	CcSEcCtD
Morphine—Nervous system disorder—Doxorubicin—ovarian cancer	9.19e-05	0.000373	CcSEcCtD
Morphine—Thrombocytopenia—Doxorubicin—ovarian cancer	9.18e-05	0.000372	CcSEcCtD
Morphine—Insomnia—Epirubicin—ovarian cancer	9.16e-05	0.000371	CcSEcCtD
Morphine—Tachycardia—Doxorubicin—ovarian cancer	9.15e-05	0.000371	CcSEcCtD
Morphine—Skin disorder—Doxorubicin—ovarian cancer	9.1e-05	0.000369	CcSEcCtD
Morphine—Paraesthesia—Epirubicin—ovarian cancer	9.09e-05	0.000369	CcSEcCtD
Morphine—Hyperhidrosis—Doxorubicin—ovarian cancer	9.06e-05	0.000367	CcSEcCtD
Morphine—Dyspnoea—Epirubicin—ovarian cancer	9.03e-05	0.000366	CcSEcCtD
Morphine—Somnolence—Epirubicin—ovarian cancer	9e-05	0.000365	CcSEcCtD
Morphine—Anorexia—Doxorubicin—ovarian cancer	8.93e-05	0.000362	CcSEcCtD
Morphine—Nausea—Docetaxel—ovarian cancer	8.92e-05	0.000362	CcSEcCtD
Morphine—Dyspepsia—Epirubicin—ovarian cancer	8.92e-05	0.000362	CcSEcCtD
Morphine—Decreased appetite—Epirubicin—ovarian cancer	8.8e-05	0.000357	CcSEcCtD
Morphine—Hypotension—Doxorubicin—ovarian cancer	8.76e-05	0.000355	CcSEcCtD
Morphine—Gastrointestinal disorder—Epirubicin—ovarian cancer	8.74e-05	0.000355	CcSEcCtD
Morphine—Fatigue—Epirubicin—ovarian cancer	8.73e-05	0.000354	CcSEcCtD
Morphine—Pain—Epirubicin—ovarian cancer	8.66e-05	0.000351	CcSEcCtD
Morphine—Constipation—Epirubicin—ovarian cancer	8.66e-05	0.000351	CcSEcCtD
Morphine—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	8.54e-05	0.000346	CcSEcCtD
Morphine—Insomnia—Doxorubicin—ovarian cancer	8.48e-05	0.000344	CcSEcCtD
Morphine—Paraesthesia—Doxorubicin—ovarian cancer	8.42e-05	0.000341	CcSEcCtD
Morphine—Dyspnoea—Doxorubicin—ovarian cancer	8.36e-05	0.000339	CcSEcCtD
Morphine—Feeling abnormal—Epirubicin—ovarian cancer	8.35e-05	0.000338	CcSEcCtD
Morphine—Somnolence—Doxorubicin—ovarian cancer	8.33e-05	0.000338	CcSEcCtD
Morphine—Gastrointestinal pain—Epirubicin—ovarian cancer	8.28e-05	0.000336	CcSEcCtD
Morphine—Dyspepsia—Doxorubicin—ovarian cancer	8.25e-05	0.000335	CcSEcCtD
Morphine—Decreased appetite—Doxorubicin—ovarian cancer	8.15e-05	0.00033	CcSEcCtD
Morphine—Gastrointestinal disorder—Doxorubicin—ovarian cancer	8.09e-05	0.000328	CcSEcCtD
Morphine—Fatigue—Doxorubicin—ovarian cancer	8.08e-05	0.000328	CcSEcCtD
Morphine—Urticaria—Epirubicin—ovarian cancer	8.05e-05	0.000326	CcSEcCtD
Morphine—Pain—Doxorubicin—ovarian cancer	8.01e-05	0.000325	CcSEcCtD
Morphine—Constipation—Doxorubicin—ovarian cancer	8.01e-05	0.000325	CcSEcCtD
Morphine—Abdominal pain—Epirubicin—ovarian cancer	8.01e-05	0.000325	CcSEcCtD
Morphine—Body temperature increased—Epirubicin—ovarian cancer	8.01e-05	0.000325	CcSEcCtD
Morphine—Feeling abnormal—Doxorubicin—ovarian cancer	7.72e-05	0.000313	CcSEcCtD
Morphine—Gastrointestinal pain—Doxorubicin—ovarian cancer	7.66e-05	0.000311	CcSEcCtD
Morphine—Hypersensitivity—Epirubicin—ovarian cancer	7.46e-05	0.000303	CcSEcCtD
Morphine—Urticaria—Doxorubicin—ovarian cancer	7.44e-05	0.000302	CcSEcCtD
Morphine—Body temperature increased—Doxorubicin—ovarian cancer	7.41e-05	0.0003	CcSEcCtD
Morphine—Abdominal pain—Doxorubicin—ovarian cancer	7.41e-05	0.0003	CcSEcCtD
Morphine—Asthenia—Epirubicin—ovarian cancer	7.27e-05	0.000295	CcSEcCtD
Morphine—Pruritus—Epirubicin—ovarian cancer	7.17e-05	0.000291	CcSEcCtD
Morphine—Diarrhoea—Epirubicin—ovarian cancer	6.93e-05	0.000281	CcSEcCtD
Morphine—Hypersensitivity—Doxorubicin—ovarian cancer	6.9e-05	0.00028	CcSEcCtD
Morphine—Asthenia—Doxorubicin—ovarian cancer	6.72e-05	0.000273	CcSEcCtD
Morphine—Dizziness—Epirubicin—ovarian cancer	6.7e-05	0.000272	CcSEcCtD
Morphine—Pruritus—Doxorubicin—ovarian cancer	6.63e-05	0.000269	CcSEcCtD
Morphine—Vomiting—Epirubicin—ovarian cancer	6.44e-05	0.000261	CcSEcCtD
Morphine—Diarrhoea—Doxorubicin—ovarian cancer	6.41e-05	0.00026	CcSEcCtD
Morphine—Rash—Epirubicin—ovarian cancer	6.39e-05	0.000259	CcSEcCtD
Morphine—Dermatitis—Epirubicin—ovarian cancer	6.38e-05	0.000259	CcSEcCtD
Morphine—Headache—Epirubicin—ovarian cancer	6.35e-05	0.000257	CcSEcCtD
Morphine—Dizziness—Doxorubicin—ovarian cancer	6.2e-05	0.000251	CcSEcCtD
Morphine—Nausea—Epirubicin—ovarian cancer	6.02e-05	0.000244	CcSEcCtD
Morphine—Vomiting—Doxorubicin—ovarian cancer	5.96e-05	0.000242	CcSEcCtD
Morphine—Rash—Doxorubicin—ovarian cancer	5.91e-05	0.00024	CcSEcCtD
Morphine—Dermatitis—Doxorubicin—ovarian cancer	5.9e-05	0.000239	CcSEcCtD
Morphine—Headache—Doxorubicin—ovarian cancer	5.87e-05	0.000238	CcSEcCtD
Morphine—Nausea—Doxorubicin—ovarian cancer	5.57e-05	0.000226	CcSEcCtD
Morphine—OPRM1—Signaling by GPCR—PIK3CG—ovarian cancer	1.28e-05	0.000394	CbGpPWpGaD
Morphine—OPRK1—GPCR downstream signaling—PIK3CB—ovarian cancer	1.28e-05	0.000394	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—CXCL8—ovarian cancer	1.28e-05	0.000392	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—TYMS—ovarian cancer	1.26e-05	0.000388	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	1.26e-05	0.000387	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—CAV1—ovarian cancer	1.25e-05	0.000385	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—PIK3CD—ovarian cancer	1.24e-05	0.000382	CbGpPWpGaD
Morphine—OPRK1—GPCR downstream signaling—CXCL8—ovarian cancer	1.23e-05	0.000378	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	1.23e-05	0.000378	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	1.23e-05	0.000378	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—IL2—ovarian cancer	1.22e-05	0.000375	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—KRAS—ovarian cancer	1.22e-05	0.000374	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—TERT—ovarian cancer	1.21e-05	0.000373	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	1.2e-05	0.00037	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—PIK3CD—ovarian cancer	1.18e-05	0.000363	CbGpPWpGaD
Morphine—OPRK1—GPCR downstream signaling—IL2—ovarian cancer	1.18e-05	0.000362	CbGpPWpGaD
Morphine—UGT2B4—Metabolism—PIK3CA—ovarian cancer	1.17e-05	0.00036	CbGpPWpGaD
Morphine—UGT2B15—Metabolism—PIK3CA—ovarian cancer	1.17e-05	0.00036	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—PIK3CB—ovarian cancer	1.16e-05	0.000358	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	1.16e-05	0.000357	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—PIK3CG—ovarian cancer	1.14e-05	0.000351	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—PPP2R1A—ovarian cancer	1.13e-05	0.000348	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—PIK3CD—ovarian cancer	1.13e-05	0.000347	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—CAV1—ovarian cancer	1.12e-05	0.000345	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—PIK3CA—ovarian cancer	1.12e-05	0.000344	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—CXCL8—ovarian cancer	1.12e-05	0.000344	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—YAP1—ovarian cancer	1.11e-05	0.00034	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	1.1e-05	0.000337	CbGpPWpGaD
Morphine—UGT1A8—Metabolism—AKT1—ovarian cancer	1.09e-05	0.000336	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—TP53—ovarian cancer	1.08e-05	0.000333	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—PIK3CB—ovarian cancer	1.08e-05	0.000333	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—ESR1—ovarian cancer	1.08e-05	0.000333	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—IL2—ovarian cancer	1.07e-05	0.000328	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	1.07e-05	0.000328	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—IL6ST—ovarian cancer	1.06e-05	0.000327	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—TERT—ovarian cancer	1.06e-05	0.000327	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—CXCL8—ovarian cancer	1.04e-05	0.00032	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—HRAS—ovarian cancer	1.04e-05	0.000318	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	1.03e-05	0.000318	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—PIK3CB—ovarian cancer	1.03e-05	0.000316	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—APC—ovarian cancer	1.02e-05	0.000314	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—PIK3CG—ovarian cancer	1.02e-05	0.000314	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—NRAS—ovarian cancer	1.02e-05	0.000314	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—CAV1—ovarian cancer	1.02e-05	0.000313	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—CYTB—ovarian cancer	1.01e-05	0.000312	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—PIK3CD—ovarian cancer	1e-05	0.000308	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—IL2—ovarian cancer	9.95e-06	0.000306	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—IL6—ovarian cancer	9.91e-06	0.000305	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—CAV1—ovarian cancer	9.85e-06	0.000303	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—PIK3CB—ovarian cancer	9.84e-06	0.000302	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—MAPK3—ovarian cancer	9.8e-06	0.000301	CbGpPWpGaD
Morphine—ABCB1—Metabolism—YAP1—ovarian cancer	9.65e-06	0.000297	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	9.64e-06	0.000296	CbGpPWpGaD
Morphine—UGT2B4—Metabolism—AKT1—ovarian cancer	9.56e-06	0.000294	CbGpPWpGaD
Morphine—UGT2B15—Metabolism—AKT1—ovarian cancer	9.56e-06	0.000294	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—ESR1—ovarian cancer	9.49e-06	0.000292	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—CXCL8—ovarian cancer	9.45e-06	0.00029	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—IL6ST—ovarian cancer	9.34e-06	0.000287	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—MAPK1—ovarian cancer	9.32e-06	0.000286	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—EGFR—ovarian cancer	9.32e-06	0.000286	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—PIK3CG—ovarian cancer	9.27e-06	0.000285	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—AKT1—ovarian cancer	9.15e-06	0.000281	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—YAP1—ovarian cancer	9.1e-06	0.000279	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—IL2—ovarian cancer	9.03e-06	0.000278	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—FASN—ovarian cancer	9.03e-06	0.000278	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—TERT—ovarian cancer	9e-06	0.000277	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—PIK3CD—ovarian cancer	8.99e-06	0.000276	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—PIK3CG—ovarian cancer	8.97e-06	0.000276	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—APC—ovarian cancer	8.97e-06	0.000276	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—NRAS—ovarian cancer	8.97e-06	0.000276	CbGpPWpGaD
Morphine—OPRD1—GPCR downstream signaling—PIK3CA—ovarian cancer	8.91e-06	0.000274	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—PTEN—ovarian cancer	8.89e-06	0.000273	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—SLC5A5—ovarian cancer	8.88e-06	0.000273	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—BRIP1—ovarian cancer	8.87e-06	0.000272	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—PPP1CC—ovarian cancer	8.87e-06	0.000272	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—KRAS—ovarian cancer	8.81e-06	0.000271	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—PIK3CB—ovarian cancer	8.74e-06	0.000269	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	8.73e-06	0.000268	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—MAPK3—ovarian cancer	8.59e-06	0.000264	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—SLC2A1—ovarian cancer	8.58e-06	0.000264	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	8.4e-06	0.000258	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—CAV1—ovarian cancer	8.32e-06	0.000256	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—CYP1B1—ovarian cancer	8.23e-06	0.000253	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—MAPK1—ovarian cancer	8.18e-06	0.000251	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—EGFR—ovarian cancer	8.17e-06	0.000251	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—PIK3CD—ovarian cancer	8.15e-06	0.000251	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—PIK3CA—ovarian cancer	8.09e-06	0.000249	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—ESR1—ovarian cancer	8.02e-06	0.000246	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—ERBB2—ovarian cancer	7.94e-06	0.000244	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—IL6ST—ovarian cancer	7.89e-06	0.000242	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—PIK3CD—ovarian cancer	7.89e-06	0.000242	CbGpPWpGaD
Morphine—ABCB1—Metabolism—FASN—ovarian cancer	7.87e-06	0.000242	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—MTOR—ovarian cancer	7.84e-06	0.000241	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—PIK3CB—ovarian cancer	7.84e-06	0.000241	CbGpPWpGaD
Morphine—OPRK1—GPCR downstream signaling—PIK3CA—ovarian cancer	7.81e-06	0.00024	CbGpPWpGaD
Morphine—ABCB1—Metabolism—SLC5A5—ovarian cancer	7.74e-06	0.000238	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—KRAS—ovarian cancer	7.72e-06	0.000237	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—APC—ovarian cancer	7.58e-06	0.000233	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—PIK3CG—ovarian cancer	7.58e-06	0.000233	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—NRAS—ovarian cancer	7.58e-06	0.000233	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—PTEN—ovarian cancer	7.56e-06	0.000232	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—CXCL8—ovarian cancer	7.53e-06	0.000232	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—HRAS—ovarian cancer	7.49e-06	0.00023	CbGpPWpGaD
Morphine—ABCB1—Metabolism—SLC2A1—ovarian cancer	7.48e-06	0.00023	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—FASN—ovarian cancer	7.41e-06	0.000228	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—CDKN1B—ovarian cancer	7.36e-06	0.000226	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—PPP2R1A—ovarian cancer	7.3e-06	0.000224	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—SLC5A5—ovarian cancer	7.29e-06	0.000224	CbGpPWpGaD
Morphine—OPRD1—GPCR downstream signaling—AKT1—ovarian cancer	7.28e-06	0.000224	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—MAPK3—ovarian cancer	7.26e-06	0.000223	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	7.26e-06	0.000223	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—CASP3—ovarian cancer	7.21e-06	0.000222	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—IL2—ovarian cancer	7.2e-06	0.000221	CbGpPWpGaD
Morphine—ABCB1—Metabolism—CYP1B1—ovarian cancer	7.17e-06	0.00022	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—IL6—ovarian cancer	7.16e-06	0.00022	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—PIK3CB—ovarian cancer	7.11e-06	0.000218	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—PIK3CA—ovarian cancer	7.09e-06	0.000218	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—SLC2A1—ovarian cancer	7.04e-06	0.000216	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—CCND1—ovarian cancer	7.02e-06	0.000216	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—ERBB2—ovarian cancer	6.97e-06	0.000214	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—CTNNB1—ovarian cancer	6.95e-06	0.000214	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—MAPK1—ovarian cancer	6.91e-06	0.000212	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—EGFR—ovarian cancer	6.91e-06	0.000212	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—MTOR—ovarian cancer	6.87e-06	0.000211	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—PIK3CB—ovarian cancer	6.87e-06	0.000211	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—MMP9—ovarian cancer	6.81e-06	0.000209	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—PTEN—ovarian cancer	6.77e-06	0.000208	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—ABCB1—ovarian cancer	6.77e-06	0.000208	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—CYP1B1—ovarian cancer	6.75e-06	0.000208	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—PIK3CD—ovarian cancer	6.67e-06	0.000205	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—TYMS—ovarian cancer	6.65e-06	0.000204	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—AKT1—ovarian cancer	6.61e-06	0.000203	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—CXCL8—ovarian cancer	6.61e-06	0.000203	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—PIK3CA—ovarian cancer	6.6e-06	0.000203	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—HRAS—ovarian cancer	6.56e-06	0.000202	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—KRAS—ovarian cancer	6.53e-06	0.000201	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—CDKN1B—ovarian cancer	6.45e-06	0.000198	CbGpPWpGaD
Morphine—OPRK1—GPCR downstream signaling—AKT1—ovarian cancer	6.38e-06	0.000196	CbGpPWpGaD
Morphine—ABCB1—Metabolism—PPP2R1A—ovarian cancer	6.36e-06	0.000195	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—CASP3—ovarian cancer	6.32e-06	0.000194	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—IL2—ovarian cancer	6.31e-06	0.000194	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—IL6—ovarian cancer	6.28e-06	0.000193	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—PIK3CA—ovarian cancer	6.27e-06	0.000193	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—CCND1—ovarian cancer	6.15e-06	0.000189	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—PTEN—ovarian cancer	6.14e-06	0.000189	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—VEGFA—ovarian cancer	6.12e-06	0.000188	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—CTNNB1—ovarian cancer	6.1e-06	0.000187	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—STAT3—ovarian cancer	6.06e-06	0.000186	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—NRAS—ovarian cancer	6.04e-06	0.000186	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—PIK3CA—ovarian cancer	6e-06	0.000184	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—PPP2R1A—ovarian cancer	5.99e-06	0.000184	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—MMP9—ovarian cancer	5.98e-06	0.000184	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—YAP1—ovarian cancer	5.95e-06	0.000183	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—PTEN—ovarian cancer	5.94e-06	0.000183	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—ERBB2—ovarian cancer	5.89e-06	0.000181	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—PIK3CB—ovarian cancer	5.81e-06	0.000179	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—MTOR—ovarian cancer	5.81e-06	0.000179	CbGpPWpGaD
Morphine—ABCB1—Metabolism—TYMS—ovarian cancer	5.8e-06	0.000178	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—AKT1—ovarian cancer	5.8e-06	0.000178	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—MAPK3—ovarian cancer	5.79e-06	0.000178	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—MYC—ovarian cancer	5.63e-06	0.000173	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—CXCL8—ovarian cancer	5.58e-06	0.000172	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—ABCB1—ovarian cancer	5.56e-06	0.000171	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—HRAS—ovarian cancer	5.55e-06	0.00017	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—MAPK1—ovarian cancer	5.51e-06	0.000169	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—EGFR—ovarian cancer	5.51e-06	0.000169	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—TYMS—ovarian cancer	5.46e-06	0.000168	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—CDKN1B—ovarian cancer	5.45e-06	0.000168	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—AKT1—ovarian cancer	5.39e-06	0.000166	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—VEGFA—ovarian cancer	5.37e-06	0.000165	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—CAV1—ovarian cancer	5.36e-06	0.000165	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—CASP3—ovarian cancer	5.34e-06	0.000164	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—IL2—ovarian cancer	5.34e-06	0.000164	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—PIK3CA—ovarian cancer	5.33e-06	0.000164	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—STAT3—ovarian cancer	5.31e-06	0.000163	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—IL6—ovarian cancer	5.31e-06	0.000163	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—NRAS—ovarian cancer	5.3e-06	0.000163	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—KRAS—ovarian cancer	5.2e-06	0.00016	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—CCND1—ovarian cancer	5.2e-06	0.00016	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—CTNNB1—ovarian cancer	5.15e-06	0.000158	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	5.12e-06	0.000157	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—AKT1—ovarian cancer	5.12e-06	0.000157	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—MAPK3—ovarian cancer	5.08e-06	0.000156	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—MMP9—ovarian cancer	5.05e-06	0.000155	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—PTEN—ovarian cancer	5.02e-06	0.000154	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—MYC—ovarian cancer	4.94e-06	0.000152	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—AKT1—ovarian cancer	4.9e-06	0.000151	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—PIK3CG—ovarian cancer	4.88e-06	0.00015	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—FASN—ovarian cancer	4.85e-06	0.000149	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—MAPK1—ovarian cancer	4.83e-06	0.000148	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—EGFR—ovarian cancer	4.83e-06	0.000148	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—PIK3CA—ovarian cancer	4.78e-06	0.000147	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—SLC5A5—ovarian cancer	4.77e-06	0.000147	CbGpPWpGaD
Morphine—ABCB1—Metabolism—CAV1—ovarian cancer	4.67e-06	0.000144	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—TP53—ovarian cancer	4.62e-06	0.000142	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—SLC2A1—ovarian cancer	4.61e-06	0.000142	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—KRAS—ovarian cancer	4.56e-06	0.00014	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—VEGFA—ovarian cancer	4.53e-06	0.000139	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—STAT3—ovarian cancer	4.49e-06	0.000138	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—NRAS—ovarian cancer	4.48e-06	0.000138	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—HRAS—ovarian cancer	4.42e-06	0.000136	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—CYP1B1—ovarian cancer	4.42e-06	0.000136	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—CAV1—ovarian cancer	4.4e-06	0.000135	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—AKT1—ovarian cancer	4.35e-06	0.000134	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—PIK3CA—ovarian cancer	4.33e-06	0.000133	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—PIK3CD—ovarian cancer	4.29e-06	0.000132	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—MAPK3—ovarian cancer	4.29e-06	0.000132	CbGpPWpGaD
Morphine—ABCB1—Metabolism—PIK3CG—ovarian cancer	4.25e-06	0.000131	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—IL6—ovarian cancer	4.23e-06	0.00013	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—PIK3CA—ovarian cancer	4.19e-06	0.000129	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—MYC—ovarian cancer	4.17e-06	0.000128	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—MAPK1—ovarian cancer	4.08e-06	0.000125	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—EGFR—ovarian cancer	4.08e-06	0.000125	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—TP53—ovarian cancer	4.05e-06	0.000125	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—PIK3CG—ovarian cancer	4.01e-06	0.000123	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	3.92e-06	0.00012	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—AKT1—ovarian cancer	3.9e-06	0.00012	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—HRAS—ovarian cancer	3.88e-06	0.000119	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—KRAS—ovarian cancer	3.86e-06	0.000118	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—PIK3CB—ovarian cancer	3.74e-06	0.000115	CbGpPWpGaD
Morphine—ABCB1—Metabolism—PIK3CD—ovarian cancer	3.74e-06	0.000115	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—IL6—ovarian cancer	3.71e-06	0.000114	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—ABCB1—ovarian cancer	3.64e-06	0.000112	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—TYMS—ovarian cancer	3.57e-06	0.00011	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—PIK3CA—ovarian cancer	3.54e-06	0.000109	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—AKT1—ovarian cancer	3.54e-06	0.000109	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—PIK3CD—ovarian cancer	3.52e-06	0.000108	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—TP53—ovarian cancer	3.43e-06	0.000105	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—AKT1—ovarian cancer	3.42e-06	0.000105	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—HRAS—ovarian cancer	3.28e-06	0.000101	CbGpPWpGaD
Morphine—ABCB1—Metabolism—PIK3CB—ovarian cancer	3.26e-06	0.0001	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—PTEN—ovarian cancer	3.23e-06	9.93e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—IL6—ovarian cancer	3.14e-06	9.64e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—PIK3CB—ovarian cancer	3.07e-06	9.44e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—AKT1—ovarian cancer	2.89e-06	8.89e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—CAV1—ovarian cancer	2.88e-06	8.84e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—PTEN—ovarian cancer	2.82e-06	8.66e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—PTEN—ovarian cancer	2.65e-06	8.16e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—PIK3CG—ovarian cancer	2.62e-06	8.05e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—PIK3CD—ovarian cancer	2.3e-06	7.08e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—PIK3CA—ovarian cancer	2.28e-06	7.01e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—PIK3CB—ovarian cancer	2.01e-06	6.17e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—PIK3CA—ovarian cancer	1.99e-06	6.11e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—PIK3CA—ovarian cancer	1.87e-06	5.75e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—AKT1—ovarian cancer	1.86e-06	5.73e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—PTEN—ovarian cancer	1.74e-06	5.33e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—AKT1—ovarian cancer	1.62e-06	4.99e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—AKT1—ovarian cancer	1.53e-06	4.7e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—PIK3CA—ovarian cancer	1.22e-06	3.76e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—AKT1—ovarian cancer	1e-06	3.07e-05	CbGpPWpGaD
